These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25580421)

  • 1. Clinical and Biochemical Profiles according to Homeostasis Model Assessment-insulin Resistance (HOMA-IR) in Korean Women with Polycystic Ovary Syndrome.
    Lee DE; Park SY; Park SY; Lee SR; Chung HW; Jeong K
    J Menopausal Med; 2014 Dec; 20(3):104-10. PubMed ID: 25580421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic disparities between obese and non-obese patients with polycystic ovary syndrome: implications for endometrial receptivity indicators.
    Li XL; Ji YF; Feng Y; Liu SW
    Gynecol Endocrinol; 2024 Dec; 40(1):2312895. PubMed ID: 38444321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Serum Omentin, CTRP9, and Vaspin in Patients with Polycystic Ovary Syndrome.
    Wang Y; Liu N; Lu J; Yang L; Wang C; Chen J; Chang W
    Evid Based Complement Alternat Med; 2022; 2022():1862404. PubMed ID: 36034953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
    Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
    Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease.
    Zhang J; Hu J; Zhang C; Jiao Y; Kong X; Wang W
    Exp Ther Med; 2018 May; 15(5):4259-4264. PubMed ID: 29725371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation analysis of myonectin levels with metabolic and hormonal disorders in patients with polycystic ovary syndrome.
    Zhang J; Chen L; Ye J
    Ann Palliat Med; 2021 Mar; 10(3):3404-3409. PubMed ID: 33752430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
    Verit FF
    Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.
    Sahin S; Eroglu M; Selcuk S; Turkgeldi L; Kozali S; Davutoglu S; Muhcu M
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2851-6. PubMed ID: 25339479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome.
    Anik Ilhan G; Yildizhan B; Pekin T
    Gynecol Endocrinol; 2019 Mar; 35(3):233-236. PubMed ID: 30303693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hyperinsulinaemia and insulin resistance on endocrine, metabolic and fertility outcomes in women with polycystic ovary syndrome undergoing ovulation induction.
    Zhang D; Yang X; Li J; Yu J; Wu X
    Clin Endocrinol (Oxf); 2019 Sep; 91(3):440-448. PubMed ID: 31222771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
    Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
    J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Xanthine oxidase activity in polycystic ovary syndrome associated with inflammatory and cardiovascular risk factors?
    Isık H; Aynıoglu O; Tımur H; Sahbaz A; Harma M; Can M; Guven B; Alptekin H; Kokturk F
    J Reprod Immunol; 2016 Aug; 116():98-103. PubMed ID: 27295433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease].
    Chen Y; Wang XJ; Jin HL; Jin L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):751-6. PubMed ID: 23980352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome.
    Kałużna M; Czlapka-Matyasik M; Kompf P; Moczko J; Wachowiak-Ochmańska K; Janicki A; Samarzewska K; Ruchała M; Ziemnicka K
    Ther Adv Endocrinol Metab; 2022; 13():20420188211066699. PubMed ID: 35035875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China.
    Huang X; Wang Q; Liu T; Pei T; Liu D; Zhu H; Huang W
    Endocrine; 2019 Jul; 65(1):81-85. PubMed ID: 30924083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenomedullin: possible predictor of insulin resistance in women with polycystic ovary syndrome.
    Sahin I; Celik O; Celik N; Keskin L; Dogru A; Dogru I; Yürekli M; Yologlu S
    J Endocrinol Invest; 2012 Jun; 35(6):553-6. PubMed ID: 21791966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.